Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:3349-3351
doi: 10.1161/CIRCULATIONAHA.105.545996
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fazio, S.
Right arrow Articles by Linton, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fazio, S.
Right arrow Articles by Linton, M. F.
Related Collections
Right arrow Other arteriosclerosis
Right arrowRelated Article

(Circulation. 2005;111:3349-3351.)
© 2005 American Heart Association, Inc.


Editorial

Interplay Between Apolipoprotein E and Scavenger Receptor Class B Type I Controls Coronary Atherosclerosis and Lifespan in the Mouse

Sergio Fazio, MD, PhD; MacRae F. Linton, MD

From the Department of Medicine, Division of Cardiovascular Medicine (S.F., M.F.L.), the Department of Pathology (S.F.), and the Department of Pharmacology (M.F.L.), Vanderbilt University Medical Center, Nashville, Tenn.

Correspondence to Sergio Fazio, MD, PhD, Vanderbilt University Medical Center, Division of Cardiovascular Medicine, Room 383 PRB, Nashville, TN 37232–6300. E-mail sergio.fazio@vanderbilt.edu


Key Words: Editorials • apolipoproteins • arteriosclerosis


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

The mouse has become a standard model for the study of atherosclerosis induced by extreme dyslipidemia in genetically modified strains such as the apolipoprotein E (apoE)–deficient or the LDL-receptor–deficient mouse. Although the process of plaque formation appears to repeat the fundamental steps of the human disease, it has been notoriously difficult to reproduce in the mouse the clinical consequences of atherosclerosis, such as myocardial infarction and stroke, that so commonly in patients signal plaque rupture or total lumen occlusion.1 The apoE-deficient mouse is a particularly interesting model because of its susceptibility to atherosclerotic lesions spanning from the aortic sinus to the abdominal aorta and involving the brachiocephalic and carotid arteries as well.2,3 It has recently been reported that the brachiocephalic plaque in the apoE-deficient mouse is prone to rupture on feeding a high-fat diet for periods as short as 8 weeks,4 but even in this setting of exaggerated hypercholesterolemia, the aortic sinus and coronary tree do not appear to be susceptible to plaque rupture. Scavenger receptor class B type I (SR-BI) is a scavenger-type receptor expressed by many tissues and accepted by consensus to represent the docking receptor for HDL in the liver. SR-BI-deficient mice have raised HDL levels and increased atherosclerosis susceptibility on fat feeding.5 ApoE and SR-BI are both expressed, among other cells, by the hepatocyte and the macrophage. ApoE is an efficient ligand for receptor-mediated lipoprotein removal by the liver, but it is also a strong acceptor of cellular cholesterol. As such, it may control the rate . . . [Full Text of this Article]


Related Article:

Diet-Induced Occlusive Coronary Atherosclerosis, Myocardial Infarction, Cardiac Dysfunction, and Premature Death in Scavenger Receptor Class B Type I-Deficient, Hypomorphic Apolipoprotein ER61 Mice
Songwen Zhang, Michael H. Picard, Eliza Vasile, Yu Zhu, Robert L. Raffai, Karl H. Weisgraber, and Monty Krieger
Circulation 2005 111: 3457-3464. [Abstract] [Full Text]



This article has been cited by other articles:


Home page
Annals of Clinical & Laboratory ScienceHome page
G. Kolovou, D. Damaskos, K. Anagnostopoulou, and D. V. Cokkinos
Apolipoprotein E Gene Polymorphism and Gender
Ann. Clin. Lab. Sci., January 1, 2009; 39(2): 120 - 133.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Cai, J. C. He, L. Zhu, X. Chen, S. Wallenstein, G. E. Striker, and H. Vlassara
Reduced Oxidant Stress and Extended Lifespan in Mice Exposed to a Low Glycotoxin Diet: Association with Increased AGER1 Expression
Am. J. Pathol., June 1, 2007; 170(6): 1893 - 1902.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Yu, W. Zhang, P. G. Yancey, M. J. Koury, Y. Zhang, S. Fazio, and M. F. Linton
Macrophage Apolipoprotein E Reduces Atherosclerosis and Prevents Premature Death in Apolipoprotein E and Scavenger Receptor-Class BI Double-Knockout Mice
Arterioscler Thromb Vasc Biol, January 1, 2006; 26(1): 150 - 156.
[Abstract] [Full Text] [PDF]